Global Health and Global Governance

Beijing Interest Group on Global Health and Global Governance

Global Health and Global Governance

Beijing Interest Group on Global Health and Global Governance

2323 333
Commentaries more

11. Joel Slawotsky, The Corporate Responsibility To Respect Human Rights: The Exemplar of Pfizer’s Failure In The Israel-Pfizer COVID-19 Vaccination Collaboration, 2023.10.26, in: Global Health and Global Governance, https://www.bigghgg.cn/p/slawotsky2.html

10. Edward Kwakwa, WHO Global Pandemic Treaty, 2022.09.25, in: Global Health and Global Governance, https://www.bigghgg.cn/p/kwakwa2.html

9. Edward Kwakwa, WTO’s MC12 decision on the TRIPS waiver, 2022.09.14, in: Global Health and Global Governance, https://www.bigghgg.cn/p/kwakwa.html

8. Joel Slawotsky, Safeguarding the Human Right of Informed Consent: Corporate Accountability in State-Private Partnerships and Responsibility for Violations of International Law, 2021.07.31, in: Global Health and Global Governance, https://www.bigghgg.cn/p/slawotsky.html

7. David Fidler, In Response to the SARS Pandemic: Concluding Observations from an Article Published in 2005 on the New International Health Regulations, 2021.03.05, in: Global Health and Global Governance, https://www.bigghgg.cn/p/fidler.html

6. Gentian Zyberi, Some Reflections on Countering the Covid-19 Pandemic: Moving from Emergency to the “New Normal” without Trampling on Human Rights?, 2020.12.12, in: Global Health and Global Governance, https://www.bigghgg.cn/p/zyberi.html

5. Armin von Bogdandy & Pedro A. Villarreal, Assessing the WHO’s COVID-19 Pandemic Response, 2020.07.16, in: Global Health and Global Governance, https://www.bigghgg.cn/p/bogdandy.html

4. Zhengxin Huo, To Fight a New Coronavirus: The Need to Target the Virus by Science and Public Health Measures, Not China by Litigation in the USA, 2020.07.21, in: Global Health and Global Governance , https://www.bigghgg.cn/p/huo.html

3. Stefan Talmon, The Scientific Research Services (SRS) of Germany’s Federal Parliament on the Chances of Success of Actions against China for Damages Incurred due to the Global Coronavirus Pandemic, 2020.06.26, in: Global Health and Global Governance , https://www.bigghgg.cn/p/talmon.html

2. Xiangqian Gong, The Obligation of a State Party to Report Matters under the International Health Regulations (2005), 2020.06.26, in: Global Health and Global Governance , https://www.bigghgg.cn/p/gong.html

News

more

Bibliographies

more

480. R Hrzic, Digital Public Health in Slovenia, 2023.10.24, https://doi.org/10.1093/eurpub/ckad160.376. The article analyses the Slovene eHealth 2010 strategy. The digitalisation of the Slovene healthcare system began in the mid-2000s with the publication of the eHealth 2010 strategy.

479. A Davis Norbye, E Hoftun Farbu, C L Terjesen, etc., Health anxiety and COVID-19: examining changes before and during the pandemic, 2023.10.24, https://doi.org/10.1093/eurpub/ckad160.1600 . This article longitudinally examines health anxiety before and during the COVID-19 pandemic in an adult, working population in Norway.

478. Neli Frost, The global “political voice deficit matrix”, 2023.11.16, https://doi.org/10.1093/icon/moad084 . This article illuminates something important yet undertheorized about the relationship between democracy, technology, and globalization.

477. Daniel Beltrán, Adam Hospital, Josep Lluís Gelpí,etc., A new paradigm for molecular dynamics databases: the COVID-19 database, the legacy of a titanic community effort, 2023.11.11, https://doi.org/10.1093/nar/gkad991 . This article presents a new paradigm for MD databases, resilient to large systems and long trajectories, and designed to be compatible with modern MD simulations. The new technology is illustrated using a collection of trajectories obtained by the community in the context of the effort to fight the COVID-19 pandemic.

476. Erica A Voss, Clair Blacketer, Sebastiaan van Sandijk, etc., European Health Data & Evidence Network—learnings from building out a standardized international health data network, 2023.11.10, https://doi.org/10.1093/jamia/ocad214. This article examines the factors that make standardizing observational health data to the Observational Medical Outcomes Partnership (OMOP) CDM successful.

Beijing Interest Group on Global Health and Global Governance
Contact: secretary@bigghgg.cn
京ICP备20029057号 京ICP备20029057号-1 京ICP备20029057号-2 京ICP备20029057号-3

Navigation